Epic Research Update : Sun Pharma Q2

Cons Net Profit At Rs 1,572 Cr Vs Rs 1,362 Cr (YoY) Cons Revenue At Rs 4,769 Cr Vs Rs 4,207 Cr (YoY) Cons EBITDA At Rs 2,180 Cr Vs Rs 1,843 Cr (YoY) Cons Operating Margin At 45.7% Vs 43.8% (YoY)

Visit Here http://www.epicresearch.co CONTACT US : +91 731 6642300 Facebook Twitter Google+